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ABSTRACT
Vaccines for infections such as measles, polio, or chicken pox contain live attenuated
viruses, which can sometimes lead to infection. Our objective is to develop an improved
strategy for vaccines that induces patent immune responses against persistent viral
infections. Three processes must occur to successfully produce immunity; the first is the
attraction of immature Dendritic Cells (DCs), loading them with particular antigens, and
then maturing the DCs.
This project focuses on DC attraction to an immunization site by fabricating crosslinked
polyethylene glycol hydrogel microspheres that encapsulate a chemoattractant. This
study was performed to determine whether the diffusion of the chemoattractant could be
controlled by varying the amount of crosslinker and by incorporating ionic groups in the
polymer matrix. It was found that the crosslinker amounts successfully altered the
release profiles of the protein. The ionic groups incorporated in the polymer matrix
effectively altered the diffusion of both positively and negatively charged protein
diffusion.
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Title: Assistant Professor of Materials Science and Engineering and Biological
Engineering
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1. Introduction
1.1 The immune system
The immune system functions as a defense against infectious microbes, but a
more inclusive definition of immunity is a reaction to foreign substances including
microbes as well as macromolecules such as proteins and polysaccharides [1]. Two
kinds of immunities exist: innate and adaptive. Innate immunity consists of cellular
and biochemical defense mechanisms. The principal components of innate immunity
include: (1) physical barriers like epithelia (2) phagocytic cells like neutrophils and
macrophages and natural killer cells (3) blood proteins (4) cytokines, which are
proteins that regulate and coordinate many of the cell functions within the body.
Adaptive immunity involves the body's ability to "remember" and respond to
exposures of the same microbe. The key components of the adaptive immune
response include lymphocytes and their products. Antigens are defined as any
foreign substance capable of inducing an immune response.
Within the adaptive immune response, two types exist, humoral immunity and
cell-mediated immunity. Antibodies that are produced by B lymphocytes/B cells
conduct humoral immunity. Humoral immunity represents the principal defense
mechanism against molecules against extracellular microbes.
T lymphocytes/T cells conduct cell-mediated immunity. The term "naive"
refers to individuals and lymphocytes that have not encountered a particular antigen.
Generally, lymphocytes are present in the blood, but are also highly concentrated in
discrete lymphoid organs where the immune responses are initiated.
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Figure 1-Role of dendritic cells in antigen capture and presentation [1].
The initiation and development of adaptive immune responses require that
antigens be captured and displayed to specific lymphocytes that are known as
antigen-presenting cells (APCs). Dendritic Cells (DCs) are the most specialized of
APCs and capture microbial antigens, transport antigens to lymphoid organs, and
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present antigens to naive T cells to initiate the immune response. Dendritic cells play
a pivotal role in antigen capture and the T cell response to protein antigens. Immature
DCs exist under the epithelia, in most organs and in the gastrointestinal and
respiratory systems. Upon engulfing an antigen, DCs mature during their migration
to the lymph nodes. The schematic in Fig. 1 depicts the DC pathway after engulfing
an antigen.
1.2 Traditional Vaccines
Traditional vaccines operate by inducing huLmoral immunitv and are most
successful on infectious agents whose antigens are relatively invariant. Attenuated and
inactivated bacterial and viral vaccines contain intact nonpathogenic microbes that are
created by treating the microbe such that it can no longer cause disease. Attenuated
viruses are not perfect because incomplete attenuation or reversion to the pathogenic
virus can occur 1II.
Another type of vaccine uses purified antigen, 'subunit' vaccines, which are
composed of polysaccharide antigens or protein; one example is the polysaccharide
vaccine against pneumococcus. These polysaccharides ineffectively induce B cell
memory, but remain in the lymph nodes for long periods most likely because the
polysaccharides slowly degrade. The polysaccharide proteins are inefficient in entering
the pathway of antigen presentation and cannot induce adaptive immunity with long
lasting memory cells.
1.3 Progress in Controlled Release Drug Delivery
Controlled drug delivery dates back to the 1960s where silicone rubber [2] and
polyethylene [3] were used as implantable drug release matrices, but the devices lacked
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degradability and required removal after their useful lifetime. Biocompatibility
represents an essential component in fabricating controlled drug delivery systems for the
body and can be achieved by using natural polymers such as cellulose [4], chitin [5] or
chitosan [6]. Alternatively, many biodegradable controlled release devices have been
explored, including poly(lactic-co-glycolic acid) (PLGA) mlicrosphlcres. I owever, the
hydrophobic nature of the polymers creates issues with low encapsulation [7], and more
importantly the degradation of PLGA damages the encapsulated protein [8]. To
overcome these issues, hydrogels have been explored as delivery mechanisms to safely
encapsulate proteins [9], [10]. The hydrophilic nature of hydrogels helps protect the
protein during synthesis and also while the protein diffuses out of the polymer matrix.
1.4 Manipulation of Dendritic Cells as a Technique for
Vaccination
Vaccines operate by creating an artificial immunity via inoculation. The patient is
inoculated with antigenic proteins, pathogen fragments or other molecular antigens.
Immunization initiates a primary immune response that generates memory T and B cells.
The delivered antigen is typically an attenuated form of the original pathogen that has
been chemically treated to reduce toxicity. The advantage of controlled release is that the
release rate can be tailored. An application of controlled release is employing zero-order
release kinetics of a drug to be used as vaccines. Controlled release solves some
problems associated with vaccines.
Secondary lymphoid organs' primary function in the body involves bringing
antigen-presenting cells and rare antigen-specific B and T lymphocytes into physical
contact at the beginning of an immune response [ 111. The exact communication process
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that occurs inside the lymphoid organs reveals a complex network of chemokines as a
trigger for particular cellular movements. Trafficking of lymphocyte migration is
achieved by a diverse family of chemokines of approximately 10-20 kDa in size. Cells
expressing appropriate chemokine receptors migrate up chemoattractant gradients toward
their source, and were first characterized for their rol i attracting cells to sites of
inflammation. In addition, chemokines have the ability to bring B and T cells into
contact with particular cells within the secondary lymphoid organs, as well as attract and
gulide antigen-presenting cells (APCs) to the lymph nodes 1121.
The complex and specific role chemokines play in the immune system make them
an appealing mechanism to exploit for immunotherapies using vaccines. These vaccines
could induce specific immune responses by targeting and attracting specific cell types to
a central location to engulf antigen. Dendritic Cells, a type of APC, are known to play a
central role in the immune response and exist in normal tissues due to the presence of
constitutively produced chemokines [131. A primary immune response occurs when DCs
engulf foreign antigens and migrate to the lymph nodes to present the capture antigens to
T cells and initiate T-cell activation [14] (illustrated in Fig. 1). A number of
chemoattractants are known to elicit directed migration of DCs and monocytes in this
context, including monocyte chemotactic protein-I (MCP-1), MCP-2, MCP-3,
macrophage inflammatory protein-1 a (MIP-1 a), MIP-1,8, Regulated upon Activation
Normal T cell Expressed and Secreted (RANTES), C5a, ,8-defensins, and bacterially
derived formyl peptides [15], 116], [171, [18], [19] and [20].
The relatively low amount of DCs in blood and peripheral tissue (approximately
1 % of the cell population 11) make vaccines that attract DCs up a concentration gradient
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more efficient and effective than traditional vaccines. Vaccines of this sort enhance the
immune response because they increase the number of DCs loaded with antigen and as a
result increase the number of naive T cells activated in the lymph nodes.
Creating novel vaccines by attracting DCs with a chemoattractant has been
expllored and iany prior studies have blIt oil this prilnciple by) illMnizillg witl DN,\
plasmids that encode the chemokines and an antigen of interest [211, [221 1231, 1241. The
chemoattractant attracts DCs and elicists an increased localization of these cells at the
injection site.
Kumamoto et al 251 implanted poly(ethylene-co-vinyl acetate) rods that released
model protein antigen and MIP-3/ . MIP-3 l is a chemoattractant for Langerhans cells
(immature DCs) and they were able to create an artificial gradient to attract LCs. LCs
wvere loaded with antigen and protective immunity against tumors were induced
efficiently. They concluded that tumor-specific immunity was inducible. Kumamoto et
al's study is not quite ideal because the implanted rod is a non-degradable device that
requires retrieval.
1.5 Problems with Hydrogels
Hydrogels offer an interesting vehicle as a controlled drug delivery device.
They offer a couple of advantages in that they do not dissolve in water or at
physiological conditions [26]. They also provide a hydrophilic environment capable
of protecting the encapsulated chemoattractant [27].
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1.6 Hypothesis
A controlled drug delivery release system that delivers a chemoattractant and
antigen can succeed where traditional vaccines have failed by providing a non-
pathogenic pathway to adaptive immunity while effectively coordinating a cell-
nlediate( iuiUne response to the antigen. (Given the romising prior restults discussed
above, we sought to develop a system, which could serve as a potential platform for
manipulating lymphocyte trafficking in immunotherapies. To this end, we examined
controlled release hydrogel microspheres as an injectable formulation that could
mimic the generation of chemoattractant gradients generated in situ in natural acute
infections and load professional APCs at an immunization site. In addition, control of
cellular chemotaxis via chemoattractant-releasing biomaterials could be a powerful
strategy for tissue engineering, (e.g., for guided angiogenesis), where guided physical
organization of multiple cell types according to wound healing or developmental
principles is of interest.
Hydrogels tend to swell significantly upon immersion in aqueous medium. As
a result, the encapsulated protein tends to diffuse out very quickly. We hoped to
combat this problem by incorporating negatively charged groups into the polymer
mesh, which is illustrated in Fig. 2. Positively-charged chemokines will temporarily
bind to the negatively-charged groups, and the resulting diffusion rate will be much
slower. We based our protocol on a modified version of a protocol from Podual et al
[28].
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Figure 2-The hydrogel theory employs negatively charged groups where
~=mesh size.
2 Experimental Methods
2.1 Materials
Polyethylene glycol methacrylate 526 (PEG-MA, Sigma-Aldrich Chemical
Co.), polyethylene glycol dimethacrylate 875 (PEG-DIMA, Sigma-Aldrich Chelnical
Co.), Methacrylic Acid (Sigma-Aldrich Chemical Co.), Silicone oil (Avocado),
sorbitan monooleate (Span8O, Sigma-Aldrich Chelnical Co., Inc.), amnloniuIL
persulfate (APS, Sigma-Aldrich Chemical Co.), sodium metabisulfite (Sigma-Aldrich
Chemical Co.), Texas Red Ovalbumin (Texas Red Ova, Molecular Probes), Texas
Red streptavidin (Molecular Probes), Texas Red avidin (Molecular Probes), and
Hexanes (Sigma-Aldrich Chemical Co.) were used as received.
2.2 Hydrogel Synthesis
The synthesis route for the PEG hydrogels is shown in Figure 3. Nitrogen
was purged for 60 minutes through 100 ml silicone oil and 100 lI Span 80 with
stirring to remove the dissolved oxygen prior to the synthesis. The protein,
depending on which one was used for the synthesis (2.5 mg Texas Red Ova, 500 tg
Texas Red Avidin, or 100 tg Texas Red Streptavidin) was added to the monomers (2
ml PEG-MA, 3 ml methacrylic acid, 200 tl PEG-DIMA) and was purged separately
for 15 minutes. The amount of crosslinker, PEG-DIMA was varied depending on
the desired release rate (200 [d, 50 [l, 10 [1).
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Figure 3-Synthesis schematic for PEG hydrogels.
The degassed monomers and protein were added to the silicone oil and Span
80 and were degassed for another 15 minutes. The mixture was equilibrated in a
water bath at 40°C for 10 minutes at which time the redox initiators were added. The
initiators were prepared by adding 10 mg APS and 10 mg sodium metabisulfite to
lml Milli-Q water. The initiators were added using a syringe. The mixture
polymerized for 5 minutes at which point it was removed from the heated water bath.
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Cleaning the particles involved stirring with 100 ml Hexanes and 1 ml Span
80. The particles precipitated out to the bottom of the beaker and the silicone oil and
hexanes were decanted off. This process was repeated 3 times to remove unreacted
monomers and silicone oil.
Once the particles were cleaned, te hydrogeCl microsphrCS Wereswcrc rL sLspcldcd
ill Phosphate Buffered Saline (PBS). A portion of these hydrogel microspheres were
frozen and lyophilized using Freeze Dry System/Freezone 4.5 (Labconco).
2.3 Size distribution
All of the hydrogel microspheres contained fluorescent protein and the size
and relative morphology of the particles could easily be obtained by fluorescence
imaging at 40x using a Zeiss Axiovert 200 microscope equipped with a motorized
stage (Ludl) and Roper Scientific CoolSnap HQ CCD camera.
2.4 Daily Sample Measurements for Release Profiles
Release profiles were created for the hydrogel microspheres to observe the
amount of protein diffusing out of the particles. A known weight of the lyophilized
particles were resuspended in 3 ml of the desired buffer and incubated at 37°C to
mimic physiological temperature. The daily sample was taken by centrifuging the
sample at 3,000 RPM for 15 minutes and drawing a 400 l sample from the
supernatant. The remaining supernatant was drawn off and discarded such that each
daily sample was additive to the previous day. The buffer was replaced with new
buffer each day.
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2.5 Fluorescence Measurements
To quantify the amount of protein diffusing out of the hydrogel microspheres
containing Texas Red Ova, Texas Red Streptavidin, and Texas Red Avidin,
fluorescence measurements were made on the supernatants collected from the
particles incubated i PBS for various times. A sectraIfltuoromIcter was used
(SpectraMax Gemini by Molecular Devices). A series of standard curves were
constructed from known concentrations of each of the proteins. The standard curves
related known concentrations to the raw fluorescence numbers. The daily samples
were pipetted into 96-well plates in 100 tl triplicate samples, and were then measured
using a SpectraMax Gemini spectrofluorometer.
2.6 Calculating the Swelling Ratio and the Diffusion Coefficient
The mesh size for some of the varied crosslinker hydrogel microspheres was
determined by measuring gel particle swelling. A known weight of lyophilized
microspheres was resuspended in 1 ml Milli-Q water, and then placed on pre-weighed
filter paper. The hydrogel microspheres were blotted until very little water was seen.
The filter paper and blotted hydrogel microspheres were weighed, and then placed in
a vacuum oven (VWR) overnight at a temperature of 70°C. Percent volume change
(% volume change) of the sample is defined as the difference of the sample weight
after drying and the wet weight. The water loss of the filter paper must be captured as
well, and this was done by placing 3 filter papers in the vacuum oven and measuring
the dry and original weight. That is also subtracted from the dry weight. Finally the
number is multiplied by 100 to obtain the percent volume change.
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The diffusion coefficient was estimated by plotting the percent of protein
released 1taken from theI release prolilCs versus tChe square rout of 1time. ThC slupc ul
the linear trendline was equated to the coefficient fiom the following equLation for-
diffTlsion from a sphere [29]. As a simplification, equation (3) was used to ind tlhe
diffusion coefficient.
6]J2J j 2 +2 ierfc . J 32 (2)
Q =4 Dt 2 (3)
QI -
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3 Results and Discussion
3.1 Fluorescence Images for Size
The following images were taken using a fluorescent microscope. Figure
4(a) contains Texas Red ovalbumin and 200 tl of crosslinker and represents the
tighltest polymer mesh of all the syinthesized particles. The particles appear to bc
polydispersed and of at least 10 ~tm in size. Figure 4(b) shows the same particles as
in Figure 4(a) and these particles are slilghtly larger (20 urn).
Figure 5(a) contains Texas Red Ova as well, but contains less crosslinker, 50
tm. This represents the median amount of crosslinker of the synthesized particles.
These hydrogel microspheres appear to be of the same size distribution as the
previous microspheres.
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Figure 1-Texas Red Ovalbumin hydrogel microspheres
containing 200 pl crosslinker.
Figure 2-Texas Red Ovalbumin hydrogel microspheres
containing 50 1 crosslinker.
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3.2 Effect of varying crosslinker on the release of protein
The amount of crosslinker added to the synthesis determines the mesh size of
the polymeric matrix. A higher amoiunt of crosslinker produces a smaller, tighter
mesh that allows for a slower diffusion of protein. A lower amount of crosslinker
produces a larger mesh size that allows for faster diffusion.
As shown ill Figuire 6, te hydrogel inicroslihcres conmling 200 t1 PEG-
DIMA exhibit a baselillne rlcase rate that releases most of the Texas Red Ova within
14 days. These microspheres release protein at logarithmic release rate.
The hydrogel mlicrospheres containing 50 ,l crosslinker rleased over twice as
fast as the 200 1l crosslinker microspheres. These microspheres release all of the
Texas Red Ova within 7 days. This result confirms out expectation that a larger
mesh size allows for faster diffusion.
The third set of hydrogel microspheres significantly reduced the crosslinker to
a mere 10 [tl. Unfortunately, these microspheres did not release along the same
trends as the 200 !a1 crosslinker and 50 [t1 crosslinker microspheres. The 10 !a1
crosslinker microspheres should have released the fastest of the three varying
crosslinker microspheres. The 10 i corsslinker microspheres released faster than the
200 p.l microspheres, but slower than the 50 1 microspheres. This problem can be
attributed to difficulty in resuspending the microspheres for the release profile
experiments. The 10 !t1 microspheres resuspended in larger pieces than the other
particles and despite the mesh theoretically being larger, the particles may have
behaved more like a bulk gel rather than individual microspheres. In this case, a
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much larger area to diffuse through would have counteracted the larger mesh size and
slowed down the protein diffusion in order to release into the surrounding medium.
3.3 Effect of pH on release
For samples with varying amounts of crosslinker, two release profiles were
conducted: one at pH=7.2 in PBS and the other at plHl=S in Tris A Buffer. Wc
lh''ptl,i:.d thatl tlc ICl:.tiCl\ l:Cd:lr.(l f t!.;, i - .! l W.i,.t v : .
(lcprotonation at highaler pl andl this exhibits increased swelling. As can be noted
from Figure 6, the significance of the difference in release rates is minimal. The pH
difference is slighlt, and the observed release rat:s arec subsequently slight as wll.
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Texas Red Ova Microspheres with Varying Crosslinker
|+ 200 ul (neutral) 
.-.- --200 ul pH=8
- 50 ul pH=8 
- 50 ul neutral
- 10 u .
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Figure 3-Texas Red Ova release profiles for varying amounts of crosslinker.
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3.4 Swelling Data and Diffusion Coefficients
The swelling ratio data shown in Table was used as another measure to
quantify whether varying the amount of crosslinker caused an increase in the mesh
size. An increase in mesh size should also exhibit an increased amount of water
absorbed upon immersion i an aqueous environment and subsequent swclling. The
swelling ratio should increase or decreased 1111amounts of crosslilnker. This trend is
confirmed for the 200 ul and 10 ld crosslinker hydrogels, but the 50 i1 crosslinker is
lower than the other two. This can be attributed to a large amount of surfactant that
was lyophilized with the hydrogel microsphcrcs (thile other two were not lyophilizcd
with surfactant). As a result, a significant portion of the weight of the 50 lI
crosslinker microspheres was due to the surfactant and not to the actual weight of the
hydrogels. The 50 l crosslinker likely contained a lower mass of gel particles.
Fewer hydrogel particles led to an estimate of less water uptake and swelling. The
surfactant in the 50 pl case accounted for 5.8% of the total weight of the hydrogels
whereas it only accounted for about 1.2% in the other syntheses, based on weight. If
the experiment were repeated, a significantly larger sample weight would be used in
order to counteract the surfactant.
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Amount of Swelling Ratio Diffusion Coefficient
Crosslinker (Wwet/Wdv) (m2/s)
200 l 4.17 3.36x10 -8
50 1 2.89 6.24 x10 -8
10 tl 5.58 3.88 x 10-8
rable I-Swvelling Ratio for varying amount ot cr (sslinker.
3.5 Effect of different isoelectric point3. o re.?ta
(avidin/streptavidin)
Avidin (pI=10.5) and Streptavidin (pI=5) were examined because they both
have very different isoelectric points. Release studies were performed at neutral pH,
but the ionic strength was varied with one set of experiments with 500mM NaCl
concentration and the other set with 1 M NaCI concentration. Since the studies were
performed at neutral pH, avidin exhibited a net positive charge and streptavidin
exhibited a net negative charge.
The release profiles in Figure 7 exhibit the trend that we expected in that, the
negatively charged streptavidin diffused out of the polymer matrix extremely fast. It
was likely repelled by the negatively charged methacrylic acid incorporated in the
polymer matrix. The streptavidin sample performed at 500 mM and 1 M exhibit
significant differences because the increased concentration of NaCl shielded the
negatively charged streptavidin and negatively charged methacrylic acid. The charge
repelling was less strong in the 1 M experiment due to the ionic shielding and allowed
for a slower diffusion of streptavidin.
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The avidin release profiles in Figure 7 exhibit a much slower diffusion rate,
which was expected. The positively charged avidin temporarily binds to the
negatively charged methacrylic acid and results in a much slower diffusion rate of
avidin. The ionic shielding that occurred for the streptavidin samples did not exist as
strongly for the avidin samples because the ionic shielding for the streptavidin
samples \was shielding a very stronlg repellilng action \llil te avidin SallIs
exhibited an attraction tihat wvas unaffected by chare shieldin1.
25 of 32
Streptavidin and Avidin Release Profiles
- . .Streptavidin 500mM solution
-Streptavidin in M
* Avidin in 500 mM
-- Avidin in 1M
Time (days)
Figure 4-Texas Red Streptavidin and Avidin Release Profiles for varying ionic strength buffers.
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4. Summary and Future Work
The charge sensitivity of the PEG hydrogel microspheres gives it interesting
properties for vaccine applications. The crosslinker amounts can be easily varied
depending on the desired release rates.
The proteins used in these studies (Texas Red Ova, Texas Red streptavidin
and avidin) were used as model proteins for chelokinlcs because chelnokillncs can
0111 b used in smaill 1ai OLI iItS, al(d it Was I cgical to CX)1 i lt \ il til e l iabrcatiol
protocol Llusing a less expcnisive protein in larger amounts until the fbricationll protocol
was perfected. The next step in this process would involve using a chemokine and
eventually attaching antigen particles to the outside of the microspheres and complete
the vaccine. Subsequent in vitro and in vivo experiments would follow to observe the
completed device experimentally and in a native, physiological environment.
Another potential application of these hydrogel microspheres involves general
delivery of drugs that require a continuous and controlled release rate.
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